Clinical Edge Journal Scan

Adverse childhood experiences associated with increased multiple sclerosis risk in women


 

Key clinical point: Women exposed to emotional and sexual abuse during childhood are at a significantly higher risk of developing multiple sclerosis (MS), with the risk being highest among women exposed to multiple abuse categories.

Major finding: Women exposed to sexual (adjusted hazard ratio [aHR, 1.65; 95% CI 1.13-2.39) and emotional (aHR 1.40; 95% CI 1.03-1.90) abuse in childhood were at a significantly higher risk of subsequently developing MS, with the risk being highest when exposed to 2 (aHR 1.66; 95% CI 1.04-2.67) or 3 (aHR 1.93; 95% CI 1.02-3.67) abuse categories vs. no abuse.

Study details: Findings are from a prospective analysis of 77,997 women with (n = 14,477) and without (n = 63,520) exposure to any form of childhood abuse.

Disclosures: The study did not declare any specific source of funding. Some authors declared receiving research grants, consulting or speaker fees, or serving as a steering committee member or on advisory board for various sources.

Source: Eid K et al. Association of adverse childhood experiences with the development of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022 (Apr 4). Doi: 10. 1136/ jnnp- 2021-328700

Recommended Reading

RMS: Extended ofatumumab treatment presents favorable benefit-risk profile in ALITHIOS study
ICYMI Multiple Sclerosis
Smoking cessation could prevent a large proportion of MS cases
ICYMI Multiple Sclerosis
Physical exercise might contribute to increased BDNF levels in MS
ICYMI Multiple Sclerosis
Clinical Edge Journal Scan Commentary: Multiple Sclerosis April 2022
ICYMI Multiple Sclerosis
Keto diet in MS tied to less disability, better quality of life
ICYMI Multiple Sclerosis
Neighborhood-level data sheds new light on racial and ethnic diversity in MS
ICYMI Multiple Sclerosis
The Enigma of MS Etiology: Find an Answer, Ask More Questions
ICYMI Multiple Sclerosis
Childhood abuse may increase risk of MS in women
ICYMI Multiple Sclerosis
MS: Fingolimod cessation safe if followed by prompt commencement of new therapy
ICYMI Multiple Sclerosis
PMS: pNfL could serve as biomarker for disability progression and drug response
ICYMI Multiple Sclerosis